Don’t miss the new July Issue of JACC Journals #HF 💥💥 - amazing RHC review in HF 🫁🫀 - optimizing hemodynamic interactions in LVAD recipients 😷 - health status in HF and Cancer 💊 And much more 💫 Eiran Gorodeski, MD, MPH Novi Tham Jenny Thibodeau, MD, MSCS Munir S Janmohamed MD FACC, FHFSA Sara Inglis

The baseline echocardiographic characteristics of RESHAPE-HF2 study are announced! A cohort of moderate and severe FMR was analyzed with less dilated ventricles than MITRA-FR and less EROA than COAPT! We are all waiting for the final results of this great multicenter trial! 😀🙏

Can multisystem inflammatory syndrome have an adult-onset? bit.ly/3VDIfZm #EHJCaseReports #CardioX Philipp Sommer Tee Joo YEO Aaysha Cader @BoldiKovacSMD Erik Rafflenbeul A.Nazmi Calik Obayda Azizy Sara Moscatelli EHJCaseReports Editor-in-Chief

In patients with RV impairment undergoing #TEER for SMR, titration of #GDMT to at least one-half of the target dose is associated with a 40% lower risk of all-cause death up to 6 years and should be pursued independent of comorbidities. bit.ly/3W7rOFZ #JACCINT

⚠️ First 🇪🇺 Consensus of MMI #imaging for evaluation&management of patients with #LVADs 🫀just published in #EHJCI 🎯 Proud to have led this together with Hatem Soliman, FRCP, FEACVI, FASE, FHEA and a great Team of Experts‼️ #HeartFailure #EchoFirst #whyCMR #yesCCT Università di Siena pubmed.ncbi.nlm.nih.gov/38965039/

⬆️number of high blood biomarkers⬆️risks of adverse clinical outcomes post-TAVI bit.ly/Biomarkers_AS. Congrats on a phenomenal study Philippe Pibarot et al. JACC Journals American College of Cardiology European Society of Cardiology Labo Dr Clavel

#RHC plays a vital role in #HF, spanning from ambulatory care to CS, #LVAD, & #Hearttx. Hemodynamic data guide critical Tx decisions & prognosis. Explore the practical guidance of RHC in this month's #JACCHF state-of-the-art review: bit.ly/3zvDDgs Navin Rajagopalan Prateeti Khazanie

CLIMB 2024 on Imaging in structural intervention Session 1. Excelent kick-off! Women As One Julia Grapsa marta sitges

Check out our latest review on #JASE about the strengths and limitations of echocardiographic parameters in assessing patients with TR before and after interventions. Great collaborative effort! onlinejase.com/article/S0894-… Luigi Denisa Muraru Nina Ajmone Marsan GallooX CH. Pedro Li

🗞️ #RESHAPE_HF2 A new trial on #MitraClip & #FMR in #HFrEF bit.ly/4f5DkJD #EJHF 🔝 Results soon at #ESCCongress European Society of Cardiology Journals European Society of Cardiology Giuseppe Galati Amr Abdin Henry Han HFAPresident Javed Butler

Excellent editorial by Marie-Annick Clavel and Philippe Pibarot on the role of DSE and calcium score for LFLGAS severity assessment doi.org/10.1016/j.jcmg… JACC Journals Paolo Springhetti Michele Tomaselli Luigi MARA Gavazzoni Noela Radu

Free for 50 days—review on Structural Cardiac Interventions in Patients with Heart Failure: authors.elsevier.com/a/1jdIG2d9GH%7… Joann Lindenfeld Dan Burkhoff MD PhD Michael Mack, MD JACC Journals American College of Cardiology European Society of Cardiology HFSA Dr. Gilbert Tang Cardiovascular Research Foundation

Structural cardiac interventions in patients with #heartfailure ✍️pcronline.com/PCR-Publicatio… This new #EAPCI/PCR Journal Club review aims to address the unmet needs in heart failure management, particularly in patients where structural heart disease coexists with HF and limits

In the RESHAPE-HF2 trial, which involved patients with moderate to severe functional mitral regurgitation who remained symptomatic despite medical therapy, transcatheter mitral-valve repair led to a lower rate of first or recurrent hospitalization for heart failure or death from

RESHAPE-HF2 shows no impact on mortality but significant reduction in HFH and improvement in KCCQ. All call for a larger trial to confirm MTEER for lower risk and lower MR severity. #ESC2024

Original Article: Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation (RESHAPE-HF) nej.md/477rpaC #ESCardio | European Society of Cardiology

supranormal ejection fraction HFpEF different entity with distinct pathophysiology and afterload and systolic stiffness/hypercontractility as disease drivers rather than fibrosis, just at the beginning here…

How to sharpen the accuracy in identifying arrhythmogenic #MVP? 🫀 Comprehensive talk by expert Victoria Delgado, live at #ESCCongress🌟 🔑 Key Insight: Multimodality imaging is the game-changer! ➡️ Go beyond MR quantification ➡️ Focus on valve characteristics 🧩 ➡️ Don’t

🔥🔥 ☠️ for phenotypes along preshock -> CS continuum 👉 jacc.org/doi/full/10.10… JACC Journals #JACCHF Critical Care Cardiology Trials Network 🎯 Hypoperfusion +/- hypotension -> ⬆️☠️ 🎯 normotensive CS -> distinct CS phenotype 🎯 Identify pre-& early shock to improve #CardiogenicShock outcomes

NEW from #EACVI! 🎯 Ready to elevate your #CVI research? This guide is your essential resource for understanding how to design, implement, and optimize clinical studies in #CVI. Take advantage of these practical insights! 📑 bit.ly/47jjQgT #echofirst #whyCMR #yesCCT